Literature DB >> 26370555

Labile and Paroxysmal Hypertension: Common Clinical Dilemmas in Need of Treatment Studies.

Samuel J Mann1.   

Abstract

Although "labile hypertension" is regularly encountered by clinicians, there is a paucity of information available to guide therapeutic decisions. This review discusses its clinical relevance, the limitations of current knowledge, and possible directions for future research and clinical management. Results of studies that assessed measures of blood pressure variability or reactivity are reviewed. The limited information about effects of antihypertensive drugs on blood pressure variability is discussed. Two different clinical presentations are differentiated: labile hypertension and paroxysmal hypertension. Labile hypertension remains a clinical impression without defined criteria or treatment guidance. Paroxysmal hypertension, also called pseudopheochromocytoma, presents as dramatic episodes of abrupt and severe blood pressure elevation. The disorder can be disabling. Although it regularly raises suspicion of a pheochromocytoma, such a tumor is found in <2 % of patients. The cause, which involves both emotional factors and the sympathetic nervous system, and treatment approaches, are presented.

Entities:  

Keywords:  Antihypertensive drugs; Blood pressure variability; Hypertension; Labile hypertension; Paroxysmal hypertension; Sympathetic nervous system

Mesh:

Substances:

Year:  2015        PMID: 26370555     DOI: 10.1007/s11886-015-0646-0

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  56 in total

1.  Pressor responses to noxious stimuli in hypertensive patients. Effects of reserpine and chlorothiazide.

Authors:  A P SHAPIRO
Journal:  Circulation       Date:  1962-08       Impact factor: 29.690

Review 2.  Prognosis in relation to blood pressure variability: pro side of the argument.

Authors:  Kazuomi Kario
Journal:  Hypertension       Date:  2015-04-27       Impact factor: 10.190

3.  Effect of isometric exercise and mental stress on blood pressure--comparative effects of propranolol and labetalol.

Authors:  M P Anand; K K Dattani; K K Datey
Journal:  Indian Heart J       Date:  1984 Jan-Feb

Review 4.  Clinical pharmacology of labetalol.

Authors:  D A Richards; B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

5.  Converting enzyme inhibition and blood pressure reactivity to psychological stressors.

Authors:  J E Dimsdale; P Mills; M Ziegler; K Leitz; R Nelesen
Journal:  Hypertension       Date:  1992-08       Impact factor: 10.190

Review 6.  Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma.

Authors:  K Pacak; W M Linehan; G Eisenhofer; M M Walther; D S Goldstein
Journal:  Ann Intern Med       Date:  2001-02-20       Impact factor: 25.391

7.  Target-organ damage in stage I hypertensive subjects with white coat and sustained hypertension: results from the HARVEST study.

Authors:  P Palatini; P Mormino; M Santonastaso; L Mos; M Dal Follo; G Zanata; A C Pessina
Journal:  Hypertension       Date:  1998-01       Impact factor: 10.190

8.  Comparative effect of propranolol and labetalol on isometric exercise and cold stress induced increase in arterial blood pressure.

Authors:  P Pandhi; P L Sharma; B K Sharma; P L Wahi
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1986-05

Review 9.  Severe paroxysmal hypertension (pseudopheochromocytoma).

Authors:  Samuel J Mann
Journal:  Curr Hypertens Rep       Date:  2008-02       Impact factor: 5.369

10.  Circulatory effects of noise.

Authors:  L Andrén; L Hansson; R Eggertsen; T Hedner; B E Karlberg
Journal:  Acta Med Scand       Date:  1983
View more
  4 in total

1.  Unexplained Symptomatic Paroxysmal Hypertension: a Diagnostic and Management Challenge.

Authors:  Kelly Dyer; Theresa E Vettese
Journal:  J Gen Intern Med       Date:  2019-11-08       Impact factor: 5.128

Review 2.  Neurogenic hypertension: pathophysiology, diagnosis and management.

Authors:  Samuel J Mann
Journal:  Clin Auton Res       Date:  2018-07-04       Impact factor: 4.435

3.  Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.

Authors:  Robert M Carey; David A Calhoun; George L Bakris; Robert D Brook; Stacie L Daugherty; Cheryl R Dennison-Himmelfarb; Brent M Egan; John M Flack; Samuel S Gidding; Eric Judd; Daniel T Lackland; Cheryl L Laffer; Christopher Newton-Cheh; Steven M Smith; Sandra J Taler; Stephen C Textor; Tanya N Turan; William B White
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

Review 4.  Pseudopheochromocytoma.

Authors:  Divya Mamilla; Melissa K Gonzales; Murray D Esler; Karel Pacak
Journal:  Endocrinol Metab Clin North Am       Date:  2019-09-18       Impact factor: 4.741

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.